Stock Code:YYB.SI
| Announcement Title | Change - Announcement of Cessation |
| Date & Time of Broadcast | Mar 6, 2018 20:19 |
| Status | New |
| Announcement Sub Title | DEMISE OF MR TAI KOK CHUAN, INDEPENDENT DIRECTOR |
| Announcement Reference | SG180306OTHRQTVD |
| Submitted By (Co./ Ind. Name) | Ng Kai Man |
| Designation | Executive Director |
| Description (Please provide a detailed description of the event in the box below) |
Demise of Mr Tai Kok Chuan, Independent Director The information set out herein in respect of Mr Tai Kok Chuan is to the best belief and knowledge of the Company. This announcement has been prepared by Arion Entertainment Singapore Limited (the "Company") and its contents have been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor") for compliance with the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist (the "Catalist Rules"). The Sponsor has not verified the contents of this announcement. This announcement has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms Keng Yeng Pheng, Associate Director, Continuing Sponsorship (Mailing address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and E-mail: sponsorship@ppcf.com.sg). |
| Additional Details | |
| Name Of Person | Tai Kok Chuan |
| Age | 61 |
| Is effective date of cessation known? | Yes |
| If yes, please provide the date | 06/03/2018 |
| Detailed Reason (s) for cessation | Passed away on 6 March 2018. |
| Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? | No |
| Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? | No |
| Any other relevant information to be provided to shareholders of the listed issuer? | No |
| Date of Appointment to current position | 09/03/2016 |
| Does the AC have a minimum of 3 members (taking into account this cessation)? | Yes |
| Number of Independent Directors currently resident in Singapore (taking into account this cessation) | 5 |
| Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Independent Director and Member of the Nominating Committee and Remuneration Committee. |
| Role and responsibilities | To perform the functions of Independent Director and fulfilling duties and responsibilities as a member of the Nominating Committee and Remuneration Committee. |
| Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries | Nil |
| Shareholding interest in the listed issuer and its subsidiaries? | Yes |
| Shareholding Details | Held 120,300,000 ordinary shares in the Company |
| Past (for the last 5 years) | TQAQI International Pte. Ltd. |
| Present |
China Medical (International) Group Limited Albedo Corporation Pte. Ltd. Albedo Sdn. Bhd. iMyth Taiwan Limited China iMyth (Hong Kong) Pte. Ltd. China iMyth Company Pte. Ltd. CMIC Hemodialysis Pte. Ltd. China iMyth (Shanghai) Co., Ltd. CMIC Hemodialysis (Hong Kong) Limited |